Cargando…

Prognostic significance of 5-fluorouracil metabolism-relating enzymes and enhanced chemosensitivity to 5-fluorouracil by 5-chloro 2,4-dihydroxy-pyridine in urothelial carcinoma

BACKGROUND: Recently, S-1, a novel 5-fluorouracil (5-FU)-based agent containing the strong dihydropyrimidine dehydrogenase (DPD) inhibitor, 5-chloro-2,4-dihydropyrimidine (CDHP) has been clinically used to treat various non-urothelial carcinomas (UC). High levels of thymidylate synthase (TS), the ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Ide, Hiroki, Kikuchi, Eiji, Hasegawa, Masanori, Kozakai, Norihide, Kosaka, Takeo, Miyajima, Akira, Oya, Mototsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522564/
https://www.ncbi.nlm.nih.gov/pubmed/22998564
http://dx.doi.org/10.1186/1471-2407-12-420
_version_ 1782253088526041088
author Ide, Hiroki
Kikuchi, Eiji
Hasegawa, Masanori
Kozakai, Norihide
Kosaka, Takeo
Miyajima, Akira
Oya, Mototsugu
author_facet Ide, Hiroki
Kikuchi, Eiji
Hasegawa, Masanori
Kozakai, Norihide
Kosaka, Takeo
Miyajima, Akira
Oya, Mototsugu
author_sort Ide, Hiroki
collection PubMed
description BACKGROUND: Recently, S-1, a novel 5-fluorouracil (5-FU)-based agent containing the strong dihydropyrimidine dehydrogenase (DPD) inhibitor, 5-chloro-2,4-dihydropyrimidine (CDHP) has been clinically used to treat various non-urothelial carcinomas (UC). High levels of thymidylate synthase (TS), the target enzyme of 5-FU and DPD which degrades the majority of 5-FU, are associated with poor prognosis in some cancers. However, only a few reports have dealt with this in UC. The aim of this study was to investigate the clinical significance of TS and DPD in upper tract urothelial carcinoma (UTUC) and evaluate the role of TS and DPD on the sensitivity of 5-FU in UC cell lines and the anti-tumor effect of S-1 in UC xenograft model. METHODS: Firstly, we evaluated the immunohistochemical expression of TS and DPD in 176 patients with UTUC to determine their prognostic significance. Secondly, the levels of TS and DPD in UC cell lines were measured by ELISA and real-time PCR. Furthermore, the association between their levels and the sensitivity to 5-FU was examined using the small interfering RNA (siRNA) specific for TS and DPD. Thirdly, the anti-tumor effect of S-1 was evaluated in UC xenograft model. RESULTS: Immunohistochemical evaluation of TS and DPD in UTUC human samples revealed that TS expression was significantly associated with stage, grade, and lymphovascular invasion and DPD expression was significantly associated with grade. Multivariate analysis revealed that high TS expression was an independent predictor of disease-specific survival in them. In in vitro study using UC cell lines, high levels of TS and DPD were associated with low response to 5-FU and these associations were confirmed with siRNA specific for TS and DPD. In in vivo study using UC xenograft model, S-1 treatment dramatically inhibited tumor growth compared to controls, tegafur, or UFT in UC tumor with a high level of DPD. CONCLUSIONS: TS plays an important role in the prognosis of UTUC and S-1 may be a key agent for UC tumor, especially with a high level of DPD.
format Online
Article
Text
id pubmed-3522564
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35225642012-12-15 Prognostic significance of 5-fluorouracil metabolism-relating enzymes and enhanced chemosensitivity to 5-fluorouracil by 5-chloro 2,4-dihydroxy-pyridine in urothelial carcinoma Ide, Hiroki Kikuchi, Eiji Hasegawa, Masanori Kozakai, Norihide Kosaka, Takeo Miyajima, Akira Oya, Mototsugu BMC Cancer Research Article BACKGROUND: Recently, S-1, a novel 5-fluorouracil (5-FU)-based agent containing the strong dihydropyrimidine dehydrogenase (DPD) inhibitor, 5-chloro-2,4-dihydropyrimidine (CDHP) has been clinically used to treat various non-urothelial carcinomas (UC). High levels of thymidylate synthase (TS), the target enzyme of 5-FU and DPD which degrades the majority of 5-FU, are associated with poor prognosis in some cancers. However, only a few reports have dealt with this in UC. The aim of this study was to investigate the clinical significance of TS and DPD in upper tract urothelial carcinoma (UTUC) and evaluate the role of TS and DPD on the sensitivity of 5-FU in UC cell lines and the anti-tumor effect of S-1 in UC xenograft model. METHODS: Firstly, we evaluated the immunohistochemical expression of TS and DPD in 176 patients with UTUC to determine their prognostic significance. Secondly, the levels of TS and DPD in UC cell lines were measured by ELISA and real-time PCR. Furthermore, the association between their levels and the sensitivity to 5-FU was examined using the small interfering RNA (siRNA) specific for TS and DPD. Thirdly, the anti-tumor effect of S-1 was evaluated in UC xenograft model. RESULTS: Immunohistochemical evaluation of TS and DPD in UTUC human samples revealed that TS expression was significantly associated with stage, grade, and lymphovascular invasion and DPD expression was significantly associated with grade. Multivariate analysis revealed that high TS expression was an independent predictor of disease-specific survival in them. In in vitro study using UC cell lines, high levels of TS and DPD were associated with low response to 5-FU and these associations were confirmed with siRNA specific for TS and DPD. In in vivo study using UC xenograft model, S-1 treatment dramatically inhibited tumor growth compared to controls, tegafur, or UFT in UC tumor with a high level of DPD. CONCLUSIONS: TS plays an important role in the prognosis of UTUC and S-1 may be a key agent for UC tumor, especially with a high level of DPD. BioMed Central 2012-09-22 /pmc/articles/PMC3522564/ /pubmed/22998564 http://dx.doi.org/10.1186/1471-2407-12-420 Text en Copyright ©2012 ide et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ide, Hiroki
Kikuchi, Eiji
Hasegawa, Masanori
Kozakai, Norihide
Kosaka, Takeo
Miyajima, Akira
Oya, Mototsugu
Prognostic significance of 5-fluorouracil metabolism-relating enzymes and enhanced chemosensitivity to 5-fluorouracil by 5-chloro 2,4-dihydroxy-pyridine in urothelial carcinoma
title Prognostic significance of 5-fluorouracil metabolism-relating enzymes and enhanced chemosensitivity to 5-fluorouracil by 5-chloro 2,4-dihydroxy-pyridine in urothelial carcinoma
title_full Prognostic significance of 5-fluorouracil metabolism-relating enzymes and enhanced chemosensitivity to 5-fluorouracil by 5-chloro 2,4-dihydroxy-pyridine in urothelial carcinoma
title_fullStr Prognostic significance of 5-fluorouracil metabolism-relating enzymes and enhanced chemosensitivity to 5-fluorouracil by 5-chloro 2,4-dihydroxy-pyridine in urothelial carcinoma
title_full_unstemmed Prognostic significance of 5-fluorouracil metabolism-relating enzymes and enhanced chemosensitivity to 5-fluorouracil by 5-chloro 2,4-dihydroxy-pyridine in urothelial carcinoma
title_short Prognostic significance of 5-fluorouracil metabolism-relating enzymes and enhanced chemosensitivity to 5-fluorouracil by 5-chloro 2,4-dihydroxy-pyridine in urothelial carcinoma
title_sort prognostic significance of 5-fluorouracil metabolism-relating enzymes and enhanced chemosensitivity to 5-fluorouracil by 5-chloro 2,4-dihydroxy-pyridine in urothelial carcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522564/
https://www.ncbi.nlm.nih.gov/pubmed/22998564
http://dx.doi.org/10.1186/1471-2407-12-420
work_keys_str_mv AT idehiroki prognosticsignificanceof5fluorouracilmetabolismrelatingenzymesandenhancedchemosensitivityto5fluorouracilby5chloro24dihydroxypyridineinurothelialcarcinoma
AT kikuchieiji prognosticsignificanceof5fluorouracilmetabolismrelatingenzymesandenhancedchemosensitivityto5fluorouracilby5chloro24dihydroxypyridineinurothelialcarcinoma
AT hasegawamasanori prognosticsignificanceof5fluorouracilmetabolismrelatingenzymesandenhancedchemosensitivityto5fluorouracilby5chloro24dihydroxypyridineinurothelialcarcinoma
AT kozakainorihide prognosticsignificanceof5fluorouracilmetabolismrelatingenzymesandenhancedchemosensitivityto5fluorouracilby5chloro24dihydroxypyridineinurothelialcarcinoma
AT kosakatakeo prognosticsignificanceof5fluorouracilmetabolismrelatingenzymesandenhancedchemosensitivityto5fluorouracilby5chloro24dihydroxypyridineinurothelialcarcinoma
AT miyajimaakira prognosticsignificanceof5fluorouracilmetabolismrelatingenzymesandenhancedchemosensitivityto5fluorouracilby5chloro24dihydroxypyridineinurothelialcarcinoma
AT oyamototsugu prognosticsignificanceof5fluorouracilmetabolismrelatingenzymesandenhancedchemosensitivityto5fluorouracilby5chloro24dihydroxypyridineinurothelialcarcinoma